APA (7th ed.) Citation

ZU, B., C, L., C, M., & K, B. (2013). The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. PharmacoEconomics, 31(11), 1063. https://doi.org/10.1007/s40273-013-0095-9

Chicago Style (17th ed.) Citation

ZU, Babar, Lessing C, Mace C, and Bissell K. "The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-income Countries." PharmacoEconomics 31, no. 11 (2013): 1063. https://doi.org/10.1007/s40273-013-0095-9.

MLA (9th ed.) Citation

ZU, Babar, et al. "The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-income Countries." PharmacoEconomics, vol. 31, no. 11, 2013, p. 1063, https://doi.org/10.1007/s40273-013-0095-9.